IONS - Ionis Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue507,666346,620283,703
Cost of Revenue---
Gross Profit507,666346,620283,703
Operating Expenses
Research Development374,644344,320322,292
Selling General and Administrative108,48848,61637,173
Non Recurring---
Total Operating Expenses---
Operating Income or Loss24,534-46,316-75,762
Income from Continuing Operations
Total Other Income/Expenses Net-3,0581,48924,588
Earnings Before Interest and Taxes21,476-44,827-51,174
Interest Expense44,75238,79536,732
Income Before Tax-23,276-83,622-87,906
Income Tax Expense-5,9802,934372
Minority Interest87,84787,84787,847
Net Income From Continuing Ops-13,659-90,539-88,278
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-13,659-90,539-88,278
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-5,970-86,556-88,278